NCT02244255 FLOMAX® Versus HYTRIN® in Patients With the Signs and Symptoms of Benign Prostatic Hyperplasia Status COMPLETED Phase PHASE4
NCT02244242 Study to Evaluate the Symptomatic Relief Effects of FLOMAX® in Patients With Signs and Symptoms of Benign Prostatic Hyperplasia Status COMPLETED Phase PHASE4
NCT02244229 Study to Evaluate the Therapeutic Action of Tamsulosin and Finasteride in Symptomatic Benign Prostatic Hyperplasia (BPH) Patients Status COMPLETED Phase PHASE4
NCT02244216 Postmarketing Surveillance Study of Berotec® N 100 µg Metered-dose Inhaler in Chronic Obstructive Respiratory Tract Disease Status COMPLETED Phase N/A
NCT02244203 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BI 60732 in Healthy Male Volunteers Status COMPLETED Phase PHASE1
NCT02244190 Bioequivalence of Two Different Oral Solutions Tipranavir Administered in Combination With Ritonavir to Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02243566 Post-marketing Surveillance Study With MicardisPlus® in Treatment of Morning Hypertension (Self-monitored by Patient) Status COMPLETED Phase N/A
NCT02243553 Effects of Tipranavir (With Ritonavir) Capsule and Liquid Formulation on Cytochrome P450 and P-glycoprotein Activity in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT02242877 TELSYS - TELmisartan Effectiveness in Isolated SYStolic Hypertension Versus Systolic/Diastolic Hypertension Patients Aged 55 or Older Status COMPLETED Phase N/A
NCT02242864 Study to Evaluate the Effect of the Treatment With Micardis® or MicardisPlus® on Blood Pressure Status COMPLETED Phase N/A
NCT02242851 Study Describing the Hypertensive Population Treated With Telmisartan and Conditions of Use by Medical Practitioners and Patients Status COMPLETED Phase N/A
NCT02242838 Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension Status COMPLETED Phase N/A
NCT02242825 Study to Evaluate the Effect of Micardis® / MicardisPlus® on Metabolic Parameters in Patients With Essential Hypertension and Diabetes Mellitus Status COMPLETED Phase N/A
NCT02242812 Telmisartan Effectiveness on Left Ventricular Mass Reduction (TELMAR) as Assessed by MRI, in Patients With Mild to Moderate Hypertension Status TERMINATED Phase PHASE4
NCT02242396 A Study of a Hypertensive Population Under Treatment With Micardis® and Micardis Plus® to Control the Early Morning BP Rise (SURGE II) Status COMPLETED Phase N/A
NCT02242383 Evaluation of Efficacy and Tolerability of Micardis® / MicardisPlus® Under Usual Daily-practice Prescribing in Patients With Hypertension Status COMPLETED Phase N/A
NCT02242370 Effectiveness of MICARDIS® (Telmisartan) on Blood Pressure Control and Quality of Live in Patients With Essential Hypertension Status COMPLETED Phase PHASE4
NCT02242357 Study to Evaluate Efficacy and Tolerability of Micardis®/Micardis® Plus in Patients With Hypertension Status COMPLETED Phase N/A
NCT02242344 Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension Status COMPLETED Phase PHASE2
NCT02242331 Post-marketing Study to Supplement Data on Safety, Tolerability and Efficacy of Micardis® With Special Emphasis on the Control of Blood Pressure Status COMPLETED Phase N/A